Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for RGEN

Stock NameRepligen Corporation
TickerRGEN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS7599161095
LEI54930006QJ0T5AUO1E71

Show aggregate RGEN holdings

News associated with RGEN

Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright
Repligen (NASDAQ:RGEN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $180.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 38.04% from the stock’s previous close. […] - 2025-05-07 05:58:48
Repligen (NASDAQ:RGEN) Given New $190.00 Price Target at JPMorgan Chase & Co.
Repligen (NASDAQ:RGEN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $200.00 to $190.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the biotechnology company’s stock. RGEN has been the subject of several other reports. Wolfe Research raised shares of Repligen […] - 2025-04-30 08:32:52
Repligen (NASDAQ:RGEN) Upgraded by Wolfe Research to Outperform Rating
Wolfe Research upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a peer perform rating to an outperform rating in a report published on Tuesday, Marketbeat.com reports. They currently have $160.00 price objective on the biotechnology company’s stock. A number of other research firms have also weighed in on RGEN. Royal Bank of Canada upped […] - 2025-04-30 08:32:47
StockNews.com Upgrades Repligen (NASDAQ:RGEN) to “Hold”
Repligen (NASDAQ:RGEN – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. A number of other research analysts have also recently commented on the company. Royal Bank of Canada increased their price target on Repligen from $203.00 to $205.00 and […] - 2025-04-30 07:45:01
Legal & General Group Plc Lowers Stock Position in Repligen Co. (NASDAQ:RGEN)
Legal & General Group Plc trimmed its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 6.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,904 shares of the biotechnology company’s stock after selling 5,698 shares during the quarter. Legal & General […] - 2025-04-17 08:57:10
Federated Hermes Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN)
Federated Hermes Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 98.4% in the 4th quarter, Holdings Channel reports. The fund owned 5,266 shares of the biotechnology company’s stock after selling 316,555 shares during the period. Federated Hermes Inc.’s holdings in Repligen were worth $758,000 as of its most recent […] - 2025-04-16 08:50:56
Repligen Co. (NASDAQ:RGEN) Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System lessened its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.3% in the fourth quarter, HoldingsChannel reports. The fund owned 69,320 shares of the biotechnology company’s stock after selling 4,664 shares during the period. California Public Employees Retirement System’s holdings in Repligen were worth $9,978,000 as of […] - 2025-04-07 08:56:54
Repligen (NASDAQ:RGEN) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Other equities analysts also recently issued reports about the stock. Canaccord Genuity Group boosted their target price on shares of Repligen from $165.00 to $170.00 and gave the […] - 2025-04-07 05:31:01
Commonwealth Equity Services LLC Sells 92 Shares of Repligen Co. (NASDAQ:RGEN)
Commonwealth Equity Services LLC cut its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 6,228 shares of the biotechnology company’s stock after selling 92 shares during the period. Commonwealth Equity Services LLC’s holdings in Repligen were worth $896,000 as of its most recent SEC […] - 2025-04-02 07:34:47
Vanguard Group Inc. Has $734.25 Million Stake in Repligen Co. (NASDAQ:RGEN)
Vanguard Group Inc. boosted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,101,090 shares of the biotechnology company’s stock after buying an additional 56,723 shares during the period. Vanguard Group Inc. owned […] - 2025-03-31 08:10:55
Repligen Co. (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price […] - 2025-03-28 06:08:54
Signaturefd LLC Acquires 124 Shares of Repligen Co. (NASDAQ:RGEN)
Signaturefd LLC lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 172.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 196 shares of the biotechnology company’s stock after purchasing an additional 124 shares during the quarter. Signaturefd LLC’s holdings in Repligen were worth $28,000 […] - 2025-03-26 08:27:02
Sum Up The Pieces: JHML Could Be Worth $82
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-20 10:59:44
Evercore ISI Begins Coverage on Repligen (NASDAQ:RGEN)
Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report released on Tuesday, Marketbeat Ratings reports. The firm set an “in-line” rating and a $155.00 price target on the biotechnology company’s stock. Evercore ISI’s price objective points to a potential upside of 6.99% from the company’s […] - 2025-03-20 06:48:59
21,303 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by Proficio Capital Partners LLC
Proficio Capital Partners LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 21,303 shares of the biotechnology company’s stock, valued at approximately $3,066,000. A number of other large investors have also […] - 2025-03-19 07:44:45
M&T Bank Corp Has $427,000 Holdings in Repligen Co. (NASDAQ:RGEN)
M&T Bank Corp cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,969 shares of the biotechnology company’s stock after selling 197 shares during the period. M&T Bank Corp’s […] - 2025-03-14 08:08:51
QRG Capital Management Inc. Has $337,000 Position in Repligen Co. (NASDAQ:RGEN)
QRG Capital Management Inc. reduced its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 35.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,342 shares of the biotechnology company’s stock after selling 1,300 shares during the period. […] - 2025-03-07 09:28:58
Proficio Capital Partners LLC Acquires New Holdings in Repligen Co. (NASDAQ:RGEN)
Proficio Capital Partners LLC bought a new stake in Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 21,303 shares of the biotechnology company’s stock, valued at approximately $3,066,000. Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings […] - 2025-03-06 11:15:38
Contrasting Repligen (NASDAQ:RGEN) & Compass Therapeutics (NASDAQ:CMPX)
Repligen (NASDAQ:RGEN – Get Free Report) and Compass Therapeutics (NASDAQ:CMPX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Repligen and Compass […] - 2025-03-06 07:39:57
Analysts Set Repligen Co. (NASDAQ:RGEN) Target Price at $181.00
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target among brokers […] - 2025-03-06 06:45:32
Truist Financial Corp Cuts Stake in Repligen Co. (NASDAQ:RGEN)
Truist Financial Corp reduced its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 11.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,953 shares of the biotechnology company’s stock after selling 378 shares during the period. Truist Financial Corp’s holdings in Repligen were worth $425,000 as of its most […] - 2025-03-05 11:34:49
New York Life Investment Management LLC Has $801,000 Holdings in Repligen Co. (NASDAQ:RGEN)
New York Life Investment Management LLC cut its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.6% in the 4th quarter, HoldingsChannel reports. The fund owned 5,562 shares of the biotechnology company’s stock after selling 455 shares during the quarter. New York Life Investment Management LLC’s holdings in Repligen were worth $801,000 […] - 2025-03-05 10:04:59
Repligen (NASDAQ:RGEN) Downgraded by StockNews.com to Sell
StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research note released on Friday morning. A number of other equities research analysts also recently weighed in on RGEN. JPMorgan Chase & Co. lifted their price target on shares of Repligen from $190.00 to $200.00 and […] - 2025-02-24 06:40:52
Repligen (NASDAQ:RGEN) Given New $200.00 Price Target at JPMorgan Chase & Co.
Repligen (NASDAQ:RGEN – Get Free Report) had its target price boosted by equities research analysts at JPMorgan Chase & Co. from $190.00 to $200.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a […] - 2025-02-23 09:44:58
New York State Teachers Retirement System Sells 100 Shares of Repligen Co. (NASDAQ:RGEN)
New York State Teachers Retirement System lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 0.2% during the fourth quarter, Holdings Channel reports. The firm owned 53,932 shares of the biotechnology company’s stock after selling 100 shares during the period. New York State Teachers Retirement System’s holdings in Repligen were worth $7,763,000 at […] - 2025-02-19 09:17:18
IWF's Underlying Holdings Imply 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-17 16:11:41
Repligen (NASDAQ:RGEN) Coverage Initiated at TD Cowen
Equities research analysts at TD Cowen initiated coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a note issued to investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $200.00 price target on the biotechnology company’s stock. TD Cowen’s price target points to a potential upside of 33.79% […] - 2025-02-12 06:59:03
Yousif Capital Management LLC Sells 867 Shares of Repligen Co. (NASDAQ:RGEN)
Yousif Capital Management LLC lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 5.1% during the 4th quarter, HoldingsChannel reports. The firm owned 16,237 shares of the biotechnology company’s stock after selling 867 shares during the quarter. Yousif Capital Management LLC’s holdings in Repligen were worth $2,337,000 as of its most […] - 2025-02-11 08:40:56

iShares Healthcare Innovation UCITS ETF USD (Acc) RGEN holdings

DateNumber of RGEN Shares HeldBase Market Value of RGEN SharesLocal Market Value of RGEN SharesChange in RGEN Shares HeldChange in RGEN Base ValueCurrent Price per RGEN Share HeldPrevious Price per RGEN Share Held
2025-05-07 (Wednesday)67,702USD 8,590,030RGEN holding decreased by -238311USD 8,590,0300USD -238,311 USD 126.88 USD 130.4
2025-05-06 (Tuesday)67,702USD 8,828,341RGEN holding decreased by -712225USD 8,828,3410USD -712,225 USD 130.4 USD 140.92
2025-05-05 (Monday)67,702USD 9,540,566RGEN holding decreased by -39944USD 9,540,5660USD -39,944 USD 140.92 USD 141.51
2025-05-02 (Friday)67,702USD 9,580,510RGEN holding increased by 291796USD 9,580,5100USD 291,796 USD 141.51 USD 137.2
2025-05-01 (Thursday)67,702USD 9,288,714RGEN holding decreased by -53485USD 9,288,7140USD -53,485 USD 137.2 USD 137.99
2025-04-30 (Wednesday)67,702RGEN holding decreased by -271USD 9,342,199RGEN holding decreased by -135276USD 9,342,199-271USD -135,276 USD 137.99 USD 139.43
2025-04-29 (Tuesday)67,973USD 9,477,475RGEN holding decreased by -285487USD 9,477,4750USD -285,487 USD 139.43 USD 143.63
2025-04-28 (Monday)67,973RGEN holding decreased by -271USD 9,762,962RGEN holding decreased by -115357USD 9,762,962-271USD -115,357 USD 143.63 USD 144.75
2025-04-25 (Friday)68,244RGEN holding decreased by -271USD 9,878,319RGEN holding decreased by -72114USD 9,878,319-271USD -72,114 USD 144.75 USD 145.23
2025-04-24 (Thursday)68,515USD 9,950,433RGEN holding increased by 262412USD 9,950,4330USD 262,412 USD 145.23 USD 141.4
2025-04-23 (Wednesday)68,515USD 9,688,021RGEN holding increased by 169232USD 9,688,0210USD 169,232 USD 141.4 USD 138.93
2025-04-22 (Tuesday)68,515USD 9,518,789RGEN holding increased by 499474USD 9,518,7890USD 499,474 USD 138.93 USD 131.64
2025-04-21 (Monday)68,515USD 9,019,315USD 9,019,315
2025-04-18 (Friday)68,515USD 8,906,950USD 8,906,9500USD 0 USD 130 USD 130
2025-04-17 (Thursday)68,515USD 8,906,950RGEN holding decreased by -143882USD 8,906,9500USD -143,882 USD 130 USD 132.1
2025-04-16 (Wednesday)68,515USD 9,050,832RGEN holding increased by 375463USD 9,050,8320USD 375,463 USD 132.1 USD 126.62
2025-04-15 (Tuesday)68,515USD 8,675,369RGEN holding decreased by -43850USD 8,675,3690USD -43,850 USD 126.62 USD 127.26
2025-04-14 (Monday)68,515USD 8,719,219USD 8,719,219
2025-04-11 (Friday)68,515RGEN holding decreased by -1626USD 8,417,753RGEN holding increased by 338211USD 8,417,753-1,626USD 338,211 USD 122.86 USD 115.19
2025-04-10 (Thursday)70,141USD 8,079,542RGEN holding decreased by -607421USD 8,079,5420USD -607,421 USD 115.19 USD 123.85
2025-04-09 (Wednesday)70,141USD 8,686,963RGEN holding increased by 1049310USD 8,686,9630USD 1,049,310 USD 123.85 USD 108.89
2025-04-08 (Tuesday)70,141RGEN holding decreased by -813USD 7,637,653RGEN holding decreased by -600816USD 7,637,653-813USD -600,816 USD 108.89 USD 116.11
2025-04-07 (Monday)70,954RGEN holding increased by 772USD 8,238,469RGEN holding increased by 382296USD 8,238,469772USD 382,296 USD 116.11 USD 111.94
2025-04-04 (Friday)70,182USD 7,856,173RGEN holding decreased by -1332054USD 7,856,1730USD -1,332,054 USD 111.94 USD 130.92
2025-04-02 (Wednesday)70,182USD 9,188,227RGEN holding increased by 169840USD 9,188,2270USD 169,840 USD 130.92 USD 128.5
2025-04-01 (Tuesday)70,182USD 9,018,387RGEN holding increased by 88429USD 9,018,3870USD 88,429 USD 128.5 USD 127.24
2025-03-31 (Monday)70,182RGEN holding decreased by -532USD 8,929,958RGEN holding decreased by -503997USD 8,929,958-532USD -503,997 USD 127.24 USD 133.41
2025-03-28 (Friday)70,714USD 9,433,955RGEN holding decreased by -262349USD 9,433,9550USD -262,349 USD 133.41 USD 137.12
2025-03-27 (Thursday)70,714USD 9,696,304RGEN holding decreased by -163349USD 9,696,3040USD -163,349 USD 137.12 USD 139.43
2025-03-26 (Wednesday)70,714USD 9,859,653RGEN holding decreased by -178199USD 9,859,6530USD -178,199 USD 139.43 USD 141.95
2025-03-25 (Tuesday)70,714USD 10,037,852RGEN holding decreased by -226285USD 10,037,8520USD -226,285 USD 141.95 USD 145.15
2025-03-24 (Monday)70,714USD 10,264,137RGEN holding increased by 362763USD 10,264,1370USD 362,763 USD 145.15 USD 140.02
2025-03-21 (Friday)70,714RGEN holding decreased by -532USD 9,901,374RGEN holding decreased by -26044USD 9,901,374-532USD -26,044 USD 140.02 USD 139.34
2025-03-20 (Thursday)71,246USD 9,927,418RGEN holding decreased by -394702USD 9,927,4180USD -394,702 USD 139.34 USD 144.88
2025-03-19 (Wednesday)71,246USD 10,322,120RGEN holding increased by 38472USD 10,322,1200USD 38,472 USD 144.88 USD 144.34
2025-03-18 (Tuesday)71,246USD 10,283,648RGEN holding decreased by -603453USD 10,283,6480USD -603,453 USD 144.34 USD 152.81
2025-03-17 (Monday)71,246USD 10,887,101RGEN holding increased by 156028USD 10,887,1010USD 156,028 USD 152.81 USD 150.62
2025-03-14 (Friday)71,246USD 10,731,073RGEN holding increased by 582793USD 10,731,0730USD 582,793 USD 150.62 USD 142.44
2025-03-13 (Thursday)71,246USD 10,148,280RGEN holding decreased by -208751USD 10,148,2800USD -208,751 USD 142.44 USD 145.37
2025-03-12 (Wednesday)71,246RGEN holding decreased by -266USD 10,357,031RGEN holding decreased by -164530USD 10,357,031-266USD -164,530 USD 145.37 USD 147.13
2025-03-11 (Tuesday)71,512USD 10,521,561RGEN holding increased by 725132USD 10,521,5610USD 725,132 USD 147.13 USD 136.99
2025-03-10 (Monday)71,512USD 9,796,429RGEN holding decreased by -1337989USD 9,796,4290USD -1,337,989 USD 136.99 USD 155.7
2025-03-07 (Friday)71,512USD 11,134,418RGEN holding decreased by -315368USD 11,134,4180USD -315,368 USD 155.7 USD 160.11
2025-03-06 (Thursday)71,512USD 11,449,786RGEN holding increased by 174489USD 11,449,7860USD 174,489 USD 160.11 USD 157.67
2025-03-05 (Wednesday)71,512USD 11,275,297RGEN holding increased by 204524USD 11,275,2970USD 204,524 USD 157.67 USD 154.81
2025-03-04 (Tuesday)71,512USD 11,070,773RGEN holding decreased by -40762USD 11,070,7730USD -40,762 USD 154.81 USD 155.38
2025-03-03 (Monday)71,512USD 11,111,535RGEN holding decreased by -277466USD 11,111,5350USD -277,466 USD 155.38 USD 159.26
2025-02-28 (Friday)71,512RGEN holding decreased by -266USD 11,389,001RGEN holding increased by 152873USD 11,389,001-266USD 152,873 USD 159.26 USD 156.54
2025-02-27 (Thursday)71,778USD 11,236,128RGEN holding decreased by -450048USD 11,236,1280USD -450,048 USD 156.54 USD 162.81
2025-02-26 (Wednesday)71,778USD 11,686,176RGEN holding increased by 96182USD 11,686,1760USD 96,182 USD 162.81 USD 161.47
2025-02-25 (Tuesday)71,778RGEN holding increased by 266USD 11,589,994RGEN holding decreased by -190893USD 11,589,994266USD -190,893 USD 161.47 USD 164.74
2025-02-24 (Monday)71,512USD 11,780,887RGEN holding increased by 411194USD 11,780,8870USD 411,194 USD 164.74 USD 158.99
2025-02-21 (Friday)71,512USD 11,369,693RGEN holding decreased by -263164USD 11,369,6930USD -263,164 USD 158.99 USD 162.67
2025-02-20 (Thursday)71,512RGEN holding decreased by -266USD 11,632,857RGEN holding increased by 813759USD 11,632,857-266USD 813,759 USD 162.67 USD 150.73
2025-02-19 (Wednesday)71,778RGEN holding increased by 532USD 10,819,098RGEN holding increased by 475604USD 10,819,098532USD 475,604 USD 150.73 USD 145.18
2025-02-18 (Tuesday)71,246RGEN holding increased by 266USD 10,343,494RGEN holding decreased by -84888USD 10,343,494266USD -84,888 USD 145.18 USD 146.92
2025-02-17 (Monday)70,980USD 10,428,382USD 10,428,3820USD 0 USD 146.92 USD 146.92
2025-02-14 (Friday)70,980USD 10,428,382RGEN holding increased by 53235USD 10,428,3820USD 53,235 USD 146.92 USD 146.17
2025-02-13 (Thursday)70,980USD 10,375,147RGEN holding increased by 31941USD 10,375,1470USD 31,941 USD 146.17 USD 145.72
2025-02-12 (Wednesday)70,980USD 10,343,206RGEN holding decreased by -267594USD 10,343,2060USD -267,594 USD 145.72 USD 149.49
2025-02-11 (Tuesday)70,980USD 10,610,800RGEN holding decreased by -310183USD 10,610,8000USD -310,183 USD 149.49 USD 153.86
2025-02-10 (Monday)70,980USD 10,920,983RGEN holding decreased by -155446USD 10,920,9830USD -155,446 USD 153.86 USD 156.05
2025-02-07 (Friday)70,980USD 11,076,429RGEN holding decreased by -412394USD 11,076,4290USD -412,394 USD 156.05 USD 161.86
2025-02-06 (Thursday)70,980USD 11,488,823RGEN holding decreased by -4968USD 11,488,8230USD -4,968 USD 161.86 USD 161.93
2025-02-05 (Wednesday)70,980USD 11,493,791RGEN holding increased by 135571USD 11,493,7910USD 135,571 USD 161.93 USD 160.02
2025-02-04 (Tuesday)70,980USD 11,358,220RGEN holding increased by 10647USD 11,358,2200USD 10,647 USD 160.02 USD 159.87
2025-02-03 (Monday)70,980USD 11,347,573RGEN holding decreased by -450013USD 11,347,5730USD -450,013 USD 159.87 USD 166.21
2025-01-31 (Friday)70,980USD 11,797,586RGEN holding decreased by -93693USD 11,797,5860USD -93,693 USD 166.21 USD 167.53
2025-01-30 (Thursday)70,980USD 11,891,279RGEN holding decreased by -132733USD 11,891,2790USD -132,733 USD 167.53 USD 169.4
2025-01-29 (Wednesday)70,980USD 12,024,012RGEN holding decreased by -343543USD 12,024,0120USD -343,543 USD 169.4 USD 174.24
2025-01-28 (Tuesday)70,980USD 12,367,555RGEN holding increased by 442205USD 12,367,5550USD 442,205 USD 174.24 USD 168.01
2025-01-27 (Monday)70,980USD 11,925,350RGEN holding increased by 150478USD 11,925,3500USD 150,478 USD 168.01 USD 165.89
2025-01-24 (Friday)70,980USD 11,774,872RGEN holding decreased by -142670USD 11,774,8720USD -142,670 USD 165.89 USD 167.9
2025-01-23 (Thursday)70,980USD 11,917,542RGEN holding increased by 75239USD 11,917,5420USD 75,239 USD 167.9 USD 166.84
2025-01-22 (Wednesday)70,980USD 11,842,303USD 11,842,303
2025-01-21 (Tuesday)71,246USD 11,963,628USD 11,963,628
2025-01-20 (Monday)71,246USD 11,435,695USD 11,435,695
2025-01-17 (Friday)71,246USD 11,435,695USD 11,435,695
2025-01-16 (Thursday)71,512USD 11,645,729USD 11,645,729
2025-01-15 (Wednesday)71,512USD 11,248,122USD 11,248,122
2025-01-14 (Tuesday)71,512USD 11,195,204USD 11,195,204
2025-01-13 (Monday)71,512USD 11,330,361USD 11,330,361
2025-01-10 (Friday)71,512USD 11,074,348USD 11,074,348
2025-01-09 (Thursday)71,512USD 11,062,906USD 11,062,906
2025-01-09 (Thursday)71,512USD 11,062,906USD 11,062,906
2025-01-09 (Thursday)71,512USD 11,062,906USD 11,062,906
2025-01-08 (Wednesday)71,512USD 11,062,906USD 11,062,906
2025-01-08 (Wednesday)71,512USD 11,062,906USD 11,062,906
2025-01-08 (Wednesday)71,512USD 11,062,906USD 11,062,906
2025-01-02 (Thursday)71,512USD 10,229,792RGEN holding decreased by -54349USD 10,229,7920USD -54,349 USD 143.05 USD 143.81
2024-12-30 (Monday)71,512RGEN holding increased by 649USD 10,284,141RGEN holding decreased by -482783USD 10,284,141649USD -482,783 USD 143.81 USD 151.94
2024-12-10 (Tuesday)70,863USD 10,766,924RGEN holding decreased by -196999USD 10,766,9240USD -196,999 USD 151.94 USD 154.72
2024-12-09 (Monday)70,863USD 10,963,923RGEN holding increased by 391163USD 10,963,9230USD 391,163 USD 154.72 USD 149.2
2024-12-06 (Friday)70,863RGEN holding decreased by -262USD 10,572,760RGEN holding increased by 454517USD 10,572,760-262USD 454,517 USD 149.2 USD 142.26
2024-12-05 (Thursday)71,125USD 10,118,243RGEN holding decreased by -485783USD 10,118,2430USD -485,783 USD 142.26 USD 149.09
2024-12-04 (Wednesday)71,125RGEN holding decreased by -262USD 10,604,026RGEN holding increased by 3056USD 10,604,026-262USD 3,056 USD 149.09 USD 148.5
2024-12-03 (Tuesday)71,387RGEN holding decreased by -524USD 10,600,970RGEN holding decreased by -218759USD 10,600,970-524USD -218,759 USD 148.5 USD 150.46
2024-12-02 (Monday)71,911USD 10,819,729RGEN holding decreased by -5753USD 10,819,7290USD -5,753 USD 150.46 USD 150.54
2024-11-29 (Friday)71,911USD 10,825,482RGEN holding increased by 39551USD 10,825,4820USD 39,551 USD 150.54 USD 149.99
2024-11-28 (Thursday)71,911USD 10,785,931USD 10,785,9310USD 0 USD 149.99 USD 149.99
2024-11-27 (Wednesday)71,911USD 10,785,931RGEN holding increased by 233711USD 10,785,9310USD 233,711 USD 149.99 USD 146.74
2024-11-26 (Tuesday)71,911USD 10,552,220RGEN holding increased by 48899USD 10,552,2200USD 48,899 USD 146.74 USD 146.06
2024-11-25 (Monday)71,911USD 10,503,321RGEN holding increased by 250251USD 10,503,3210USD 250,251 USD 146.06 USD 142.58
2024-11-22 (Friday)71,911RGEN holding increased by 599USD 10,253,070RGEN holding increased by 143881USD 10,253,070599USD 143,881 USD 142.58 USD 141.76
2024-11-21 (Thursday)71,312RGEN holding decreased by -260USD 10,109,189RGEN holding increased by 167838USD 10,109,189-260USD 167,838 USD 141.76 USD 138.9
2024-11-20 (Wednesday)71,572RGEN holding decreased by -261USD 9,941,351RGEN holding increased by 711529USD 9,941,351-261USD 711,529 USD 138.9 USD 128.49
2024-11-19 (Tuesday)71,833RGEN holding decreased by -261USD 9,229,822RGEN holding increased by 332701USD 9,229,822-261USD 332,701 USD 128.49 USD 123.41
2024-11-18 (Monday)72,094RGEN holding decreased by -1036USD 8,897,121RGEN holding decreased by -1969266USD 8,897,121-1,036USD -1,969,266 USD 123.41 USD 148.59
2024-11-12 (Tuesday)73,130RGEN holding decreased by -259USD 10,866,387RGEN holding increased by 540555USD 10,866,387-259USD 540,555 USD 148.59 USD 140.7
2024-11-08 (Friday)73,389USD 10,325,832RGEN holding decreased by -233377USD 10,325,8320USD -233,377 USD 140.7 USD 143.88
2024-11-07 (Thursday)73,389RGEN holding decreased by -259USD 10,559,209RGEN holding decreased by -188244USD 10,559,209-259USD -188,244 USD 143.88 USD 145.93
2024-11-06 (Wednesday)73,648USD 10,747,453RGEN holding decreased by -1473USD 10,747,4530USD -1,473 USD 145.93 USD 145.95
2024-11-05 (Tuesday)73,648RGEN holding decreased by -518USD 10,748,926RGEN holding increased by 400544USD 10,748,926-518USD 400,544 USD 145.95 USD 139.53
2024-11-04 (Monday)74,166USD 10,348,382RGEN holding increased by 68233USD 10,348,3820USD 68,233 USD 139.53 USD 138.61
2024-11-01 (Friday)74,166USD 10,280,149RGEN holding increased by 321880USD 10,280,1490USD 321,880 USD 138.61 USD 134.27
2024-10-31 (Thursday)74,166USD 9,958,269RGEN holding decreased by -156490USD 9,958,2690USD -156,490 USD 134.27 USD 136.38
2024-10-30 (Wednesday)74,166USD 10,114,759RGEN holding increased by 111991USD 10,114,7590USD 111,991 USD 136.38 USD 134.87
2024-10-29 (Tuesday)74,166USD 10,002,768RGEN holding decreased by -173549USD 10,002,7680USD -173,549 USD 134.87 USD 137.21
2024-10-28 (Monday)74,166RGEN holding decreased by -259USD 10,176,317RGEN holding increased by 95451USD 10,176,317-259USD 95,451 USD 137.21 USD 135.45
2024-10-25 (Friday)74,425USD 10,080,866RGEN holding increased by 20094USD 10,080,8660USD 20,094 USD 135.45 USD 135.18
2024-10-24 (Thursday)74,425USD 10,060,772RGEN holding decreased by -171177USD 10,060,7720USD -171,177 USD 135.18 USD 137.48
2024-10-23 (Wednesday)74,425USD 10,231,949RGEN holding decreased by -495671USD 10,231,9490USD -495,671 USD 137.48 USD 144.14
2024-10-22 (Tuesday)74,425USD 10,727,620RGEN holding decreased by -377334USD 10,727,6200USD -377,334 USD 144.14 USD 149.21
2024-10-21 (Monday)74,425USD 11,104,954RGEN holding increased by 168200USD 11,104,9540USD 168,200 USD 149.21 USD 146.95
2024-10-18 (Friday)74,425USD 10,936,754USD 10,936,754
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RGEN by Blackrock for IE00BYZK4776

Show aggregate share trades of RGEN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-30SELL-271 137.990* 145.26 Profit of 39,366 on sale
2025-04-28SELL-271 143.630* 145.34 Profit of 39,387 on sale
2025-04-25SELL-271 144.750* 145.34 Profit of 39,388 on sale
2025-04-11SELL-1,626 122.860* 146.41 Profit of 238,057 on sale
2025-04-08SELL-813 108.890* 147.46 Profit of 119,881 on sale
2025-04-07BUY772 116.110* 147.82
2025-03-31SELL-532 127.240* 148.95 Profit of 79,242 on sale
2025-03-21SELL-532 140.020* 149.70 Profit of 79,638 on sale
2025-03-12SELL-266 145.370* 150.10 Profit of 39,927 on sale
2025-02-28SELL-266 159.260* 149.67 Profit of 39,813 on sale
2025-02-25BUY266 161.470* 149.12
2025-02-20SELL-266 162.670* 148.41 Profit of 39,478 on sale
2025-02-19BUY532 150.730* 148.37
2025-02-18BUY266 145.180* 148.43
2024-12-30BUY649 143.810* 142.79
2024-12-06SELL-262 149.200* 141.87 Profit of 37,170 on sale
2024-12-04SELL-262 149.090* 141.60 Profit of 37,099 on sale
2024-12-03SELL-524 148.500* 141.34 Profit of 74,064 on sale
2024-11-22BUY599 142.580* 139.00
2024-11-21SELL-260 141.760* 138.85 Profit of 36,101 on sale
2024-11-20SELL-261 138.900* 138.85 Profit of 36,240 on sale
2024-11-19SELL-261 128.490* 139.46 Profit of 36,399 on sale
2024-11-18SELL-1,036 123.410* 140.46 Profit of 145,518 on sale
2024-11-12SELL-259 148.590* 139.92 Profit of 36,239 on sale
2024-11-07SELL-259 143.880* 139.55 Profit of 36,145 on sale
2024-11-05SELL-518 145.950* 138.39 Profit of 71,688 on sale
2024-10-28SELL-259 137.210* 140.29 Profit of 36,336 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RGEN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-08118,054142207,19957.0%
2025-05-07241,492128625,39438.6%
2025-05-06387,4008,111557,13269.5%
2025-05-05205,38174294,24169.8%
2025-05-02147,12542231,23663.6%
2025-05-01101,145863176,12457.4%
2025-04-30264,4163381,53669.3%
2025-04-29615,3366,7491,017,64060.5%
2025-04-28202,87521421,68448.1%
2025-04-25108,76333191,68456.7%
2025-04-24143,013652215,76466.3%
2025-04-23159,3662,750264,03660.4%
2025-04-22320,58643523,17461.3%
2025-04-21194,64089273,09371.3%
2025-04-17193,5300296,85565.2%
2025-04-16362,8405,845481,91075.3%
2025-04-15172,4532,278295,30758.4%
2025-04-14194,85726273,57771.2%
2025-04-11207,6986,355447,11246.5%
2025-04-10201,9921,134344,45858.6%
2025-04-09175,0071,537521,36433.6%
2025-04-08220,0920470,54246.8%
2025-04-07352,46810,595676,95452.1%
2025-04-04305,8767,142711,47943.0%
2025-04-03150,60138354,27542.5%
2025-04-0298,01221237,52741.3%
2025-04-0195,69329215,86744.3%
2025-03-31155,5330397,89939.1%
2025-03-28117,697105298,18339.5%
2025-03-2740,997084,90148.3%
2025-03-2652,650505128,59140.9%
2025-03-2569,2120128,09154.0%
2025-03-2475,4010151,77249.7%
2025-03-2166,0230143,89545.9%
2025-03-2062,20569137,19445.3%
2025-03-1969,792445239,86329.1%
2025-03-18145,1490543,15726.7%
2025-03-1790,28640160,98856.1%
2025-03-1465,89314126,35252.2%
2025-03-1396,1266,043180,01753.4%
2025-03-1291,5940207,77044.1%
2025-03-11143,8432,070317,56845.3%
2025-03-10208,206152543,55638.3%
2025-03-0771,9460355,04220.3%
2025-03-06161,961342219,60573.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.